Loss of either RSPO1 or LGR4 increases the risk of developing squamous cell carcinoma of the skin, indicating that RSPO1-LGR4 signaling plays a vital role in the negative regulation of cell proliferation in the skin. This evidence concerns the gene LGR4 and skin squamous cell carcinoma.